CYAD - セリアド (Celyad SA) セリアド

 CYADのチャート


 CYADの企業情報

symbol CYAD
会社名 Celyad SA (セリアド)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   セリアドはベルギ―のバイオ医薬品企業。主に心不全や心筋梗塞などの心臓疾患の治療法の発見、開発、商業化に従事する。バイオ治療薬を心臓の筋肉に注入するためのカテ―テル「C-CATHez」を提供。また、慢性心不全や虚血性心筋症の治療向けに臨床段階の主力薬剤である「C-Cure」を提供する。新薬候補にはタンパク質ベ―スの薬剤も扱う。   
本社所在地 Rue Edouard Belin 12 Mont-Saint-Guibert 1435 BEL
代表者氏名
代表者役職名
電話番号
設立年月日 39264
市場名 NASDAQ National Market System
ipoyear 2015年
従業員数 76人
url www.C3BS.com
nasdaq_url https://www.nasdaq.com/symbol/cyad
adr_tso 883561
EBITDA EBITDA ー
終値(lastsale) 25
時価総額(marketcap) 22089025
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 CYADのテクニカル分析


 CYADのニュース

   Celyad to sell cell therapy manufacturing site to Cellistic for €6M  2022/09/20 10:17:18 Seeking Alpha
Ncardia''s unit Cellistic is acquiring Celyad Oncology''s (CYAD) cell therapy manufacturing facility and related personnel (the manufacturing business unit) in Mont-Saint-Guibert,…
   Earnings Scheduled For August 5, 2022  2022/08/05 08:49:57 Benzinga
Companies Reporting Before The Bell • Reservoir Media (NASDAQ: RSVR ) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. • OFS Capital (NASDAQ: OFS ) is estimated to report earnings for its second quarter. • Vector Group (NYSE: VGR ) is expected to report quarterly earnings at $0.35 per share on revenue of $337.70 million. • Aldeyra Therapeutics (NASDAQ: ALDX ) is estimated to report earnings for its second quarter. • Ocugen (NASDAQ: OCGN ) is estimated to report earnings for its second quarter. • Fluor (NYSE: FLR ) is likely to report earnings for its second quarter. • Brookfield Business (NYSE: BBUC ) is expected to report earnings for its second quarter. • Celyad Oncology (NASDAQ: CYAD ) is expected to report earnings for its first quarter. • Perma-Fix Envirn Servs (NASDAQ: PESI ) is likely to report earnings for its second quarter. • Element Solutions (NYSE: ESI ) is likely to report quarterly loss at $0.15 per share on revenue of $321.97 million.
   U.S. Stocks Turn Negative; Dow Drops Over 100 Points  2022/08/01 18:39:12 Benzinga
U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.43% to 32,703.03 while the NASDAQ fell 0.58% to 12,318.87. The S&P also fell, dropping, 0.65% to 4,102.85. Also check this: Bitcoin, Ethereum Record Losses; Here Are Other Crypto Movers That Should Be On Your Radar Today Leading and Lagging Sectors Consumer staples shares climbed 1.3% on Monday. Meanwhile, top gainers in the sector included Bridgford Foods Corporation (NASDAQ: BRID ), up 15% and Celsius Holdings, Inc. (NASDAQ: CELH ) up 12%. In trading on Monday, energy shares fell 3.2%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 36% to $8.47 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 40% to $2.4399.
   U.S. Stocks Turn Higher; Crude Oil Tumbles  2022/08/01 16:21:42 Benzinga
U.S. stocks turned higher midway through trading, after recording gains in the previous session. The Dow traded up 0.29% to 32,939.84 while the NASDAQ rose 0.65% to 12,471.17. The S&P also rose, gaining, 0.24% to 4,140.40. Also check this: Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday''s Mid-Day Session Leading and Lagging Sectors Consumer discretionary shares climbed 1.6% on Monday. Meanwhile, top gainers in the sector included Golden Sun Education Group Limited (NASDAQ: GSUN ), up 17% and Volta Inc. (NYSE: VLTA ) up 17%. In trading on Monday, energy shares fell 2.6%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 21% to $7.54 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 45% to $2.52.
   Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today  2022/08/01 16:12:00 Marketing Sentinel
In today’s recent session, 5.07 million shares of the Celyad Oncology SA (NASDAQ:CYAD) were traded. Most recently the company’s share price was $2.32, and it changed around $0.51 or 28.18% from the last close, which brings the market valuation of the company to $40.90M. CYAD at last check was trading at a discount to its … Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today Read More »
   Celyad to sell cell therapy manufacturing site to Cellistic for €6M  2022/09/20 10:17:18 Seeking Alpha
Ncardia''s unit Cellistic is acquiring Celyad Oncology''s (CYAD) cell therapy manufacturing facility and related personnel (the manufacturing business unit) in Mont-Saint-Guibert,…
   Earnings Scheduled For August 5, 2022  2022/08/05 08:49:57 Benzinga
Companies Reporting Before The Bell • Reservoir Media (NASDAQ: RSVR ) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. • OFS Capital (NASDAQ: OFS ) is estimated to report earnings for its second quarter. • Vector Group (NYSE: VGR ) is expected to report quarterly earnings at $0.35 per share on revenue of $337.70 million. • Aldeyra Therapeutics (NASDAQ: ALDX ) is estimated to report earnings for its second quarter. • Ocugen (NASDAQ: OCGN ) is estimated to report earnings for its second quarter. • Fluor (NYSE: FLR ) is likely to report earnings for its second quarter. • Brookfield Business (NYSE: BBUC ) is expected to report earnings for its second quarter. • Celyad Oncology (NASDAQ: CYAD ) is expected to report earnings for its first quarter. • Perma-Fix Envirn Servs (NASDAQ: PESI ) is likely to report earnings for its second quarter. • Element Solutions (NYSE: ESI ) is likely to report quarterly loss at $0.15 per share on revenue of $321.97 million.
   U.S. Stocks Turn Negative; Dow Drops Over 100 Points  2022/08/01 18:39:12 Benzinga
U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.43% to 32,703.03 while the NASDAQ fell 0.58% to 12,318.87. The S&P also fell, dropping, 0.65% to 4,102.85. Also check this: Bitcoin, Ethereum Record Losses; Here Are Other Crypto Movers That Should Be On Your Radar Today Leading and Lagging Sectors Consumer staples shares climbed 1.3% on Monday. Meanwhile, top gainers in the sector included Bridgford Foods Corporation (NASDAQ: BRID ), up 15% and Celsius Holdings, Inc. (NASDAQ: CELH ) up 12%. In trading on Monday, energy shares fell 3.2%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 36% to $8.47 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 40% to $2.4399.
   U.S. Stocks Turn Higher; Crude Oil Tumbles  2022/08/01 16:21:42 Benzinga
U.S. stocks turned higher midway through trading, after recording gains in the previous session. The Dow traded up 0.29% to 32,939.84 while the NASDAQ rose 0.65% to 12,471.17. The S&P also rose, gaining, 0.24% to 4,140.40. Also check this: Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday''s Mid-Day Session Leading and Lagging Sectors Consumer discretionary shares climbed 1.6% on Monday. Meanwhile, top gainers in the sector included Golden Sun Education Group Limited (NASDAQ: GSUN ), up 17% and Volta Inc. (NYSE: VLTA ) up 17%. In trading on Monday, energy shares fell 2.6%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 21% to $7.54 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 45% to $2.52.
   Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today  2022/08/01 16:12:00 Marketing Sentinel
In today’s recent session, 5.07 million shares of the Celyad Oncology SA (NASDAQ:CYAD) were traded. Most recently the company’s share price was $2.32, and it changed around $0.51 or 28.18% from the last close, which brings the market valuation of the company to $40.90M. CYAD at last check was trading at a discount to its … Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today Read More »
   Celyad to sell cell therapy manufacturing site to Cellistic for €6M  2022/09/20 10:17:18 Seeking Alpha
Ncardia''s unit Cellistic is acquiring Celyad Oncology''s (CYAD) cell therapy manufacturing facility and related personnel (the manufacturing business unit) in Mont-Saint-Guibert,…
   Earnings Scheduled For August 5, 2022  2022/08/05 08:49:57 Benzinga
Companies Reporting Before The Bell • Reservoir Media (NASDAQ: RSVR ) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. • OFS Capital (NASDAQ: OFS ) is estimated to report earnings for its second quarter. • Vector Group (NYSE: VGR ) is expected to report quarterly earnings at $0.35 per share on revenue of $337.70 million. • Aldeyra Therapeutics (NASDAQ: ALDX ) is estimated to report earnings for its second quarter. • Ocugen (NASDAQ: OCGN ) is estimated to report earnings for its second quarter. • Fluor (NYSE: FLR ) is likely to report earnings for its second quarter. • Brookfield Business (NYSE: BBUC ) is expected to report earnings for its second quarter. • Celyad Oncology (NASDAQ: CYAD ) is expected to report earnings for its first quarter. • Perma-Fix Envirn Servs (NASDAQ: PESI ) is likely to report earnings for its second quarter. • Element Solutions (NYSE: ESI ) is likely to report quarterly loss at $0.15 per share on revenue of $321.97 million.
   U.S. Stocks Turn Negative; Dow Drops Over 100 Points  2022/08/01 18:39:12 Benzinga
U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.43% to 32,703.03 while the NASDAQ fell 0.58% to 12,318.87. The S&P also fell, dropping, 0.65% to 4,102.85. Also check this: Bitcoin, Ethereum Record Losses; Here Are Other Crypto Movers That Should Be On Your Radar Today Leading and Lagging Sectors Consumer staples shares climbed 1.3% on Monday. Meanwhile, top gainers in the sector included Bridgford Foods Corporation (NASDAQ: BRID ), up 15% and Celsius Holdings, Inc. (NASDAQ: CELH ) up 12%. In trading on Monday, energy shares fell 3.2%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 36% to $8.47 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 40% to $2.4399.
   U.S. Stocks Turn Higher; Crude Oil Tumbles  2022/08/01 16:21:42 Benzinga
U.S. stocks turned higher midway through trading, after recording gains in the previous session. The Dow traded up 0.29% to 32,939.84 while the NASDAQ rose 0.65% to 12,471.17. The S&P also rose, gaining, 0.24% to 4,140.40. Also check this: Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday''s Mid-Day Session Leading and Lagging Sectors Consumer discretionary shares climbed 1.6% on Monday. Meanwhile, top gainers in the sector included Golden Sun Education Group Limited (NASDAQ: GSUN ), up 17% and Volta Inc. (NYSE: VLTA ) up 17%. In trading on Monday, energy shares fell 2.6%. Top Headline The ISM manufacturing PMI fell to 52.8 in July from 53 in the previous month. However, analysts were expecting a reading of 52. Equities Trading UP TherapeuticsMD, Inc. (NASDAQ: TXMD ) shares shot up 21% to $7.54 after the company announced it has received a $15 million private investment from Rubric Capital Management. Shares of Celyad Oncology SA (NASDAQ: CYAD ) got a boost, shooting 45% to $2.52.
   Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today  2022/08/01 16:12:00 Marketing Sentinel
In today’s recent session, 5.07 million shares of the Celyad Oncology SA (NASDAQ:CYAD) were traded. Most recently the company’s share price was $2.32, and it changed around $0.51 or 28.18% from the last close, which brings the market valuation of the company to $40.90M. CYAD at last check was trading at a discount to its … Celyad Oncology SA (NASDAQ: CYAD): It Is A Stock Worth Considering Today Read More »

 関連キーワード  (― 米国株 セリアド CYAD Celyad SA)

 twitter  (公式ツイッターやCEOツイッターなど)